iBio, Inc. (IBIO)
1.81
+0.10
(+5.85%)
USD |
NASDAQ |
Dec 31, 10:47
iBio Free Cash Flow: -17.30M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Minerva Neurosciences, Inc. | -14.20M |
| Bionano Genomics, Inc. | -18.98M |
| Vor Biopharma, Inc. | -144.67M |
| Recursion Pharmaceuticals, Inc. | -450.20M |
| Senti Biosciences, Inc. | -50.28M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.665M |
| Cash from Investing (Quarterly) | -21.49M |
| Cash from Financing (Quarterly) | 46.70M |
| Free Cash Flow Per Share (Quarterly) | -0.1075 |
| Free Cash Flow to Equity (Quarterly) | -5.483M |
| Free Cash Flow to Firm (Quarterly) | -5.661M |
| Free Cash Flow Yield | -43.25% |